GH Research (GHRS) Return on Equity [ROE] (2021 - 2026)
GH Research's Return on Equity [ROE] came in at -19.78% for Q2 2026, down 5.68 percentage points from -14.10% a year earlier but up 0.75 percentage points from the prior quarter.
Powered by 
Analysis
GH Research (GHRS) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, GH Research's Return on Equity [ROE] was -20.76%, down 0.05 percentage points from FY2024.
- Return on Equity [ROE] has declined in each of the last three years, with a three-year change of -12.23 percentage points (FY2022 to FY2025).
- Going back by year, Return on Equity [ROE] was -20.70% in FY2024 (-6.56 pp), -14.14% in FY2023 (-5.62 pp) and -8.52% in FY2022.
- The five-year range for quarterly Return on Equity [ROE] is -22.37% (Q4 2024) to -5.46% (Q4 2021).
- Year-over-year, Return on Equity [ROE] increased in three of the last eight quarters, with an average year-over-year change of -1.20 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2025 (a gain of 5.70 percentage points), and the weakest in Q3 2023 (a drop of 11.65 percentage points).
- Business Quant data shows GHRS's Return on Equity [ROE] at -20.53% (Q1 2026), -16.67% (Q4 2025) and -15.19% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | GH Research | 1.42 Bn | 262.62 Mn | - | -19.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.78% |
| Mar 31, 2026 | -20.53% |
| Dec 31, 2025 | -16.67% |
| Sep 30, 2025 | -15.19% |
| Jun 30, 2025 | -14.10% |
| Mar 31, 2025 | -18.13% |
| Dec 31, 2024 | -22.37% |
| Sep 30, 2024 | -20.10% |
| Jun 30, 2024 | -15.93% |
| Mar 31, 2024 | -13.94% |
| Dec 31, 2023 | -14.91% |
| Sep 30, 2023 | -17.83% |
| Jun 30, 2023 | -15.03% |
| Mar 31, 2023 | -11.24% |
| Dec 31, 2022 | -8.87% |
| Sep 30, 2022 | -6.18% |
| Jun 30, 2022 | -6.56% |
| Mar 31, 2022 | -7.29% |
| Dec 31, 2021 | -5.46% |
API Access
GH Research Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "GHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();